TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Interdisciplinary Knowledge Translation Intervention in Long-term Care: The Vitamin D and Osteoporosis Study (ViDOS) Pilot Cluster Randomized Controlled Trial
Brief Summary: The research question is, does a multifaceted, multidisciplinary intervention including small groups, chart audits and point of care tools, increase the number of people receiving optimal vitamin D therapy in the long term care (LTC) setting? Secondary outcomes include the number of falls and fractures experienced by the residents in each LTC home and the number of residents receiving appropriate bisphosphonate therapy.


Options:
A: Arm Label: LTC Osteoporosis Toolkit Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Educ sessions & LTC Osteoporosis toolkit; Type: ACTIVE_COMPARATOR; Interventions: Other: Educ sessions & LTC Osteoporosis toolkit | Intervention Type: OTHER; Name: Educ sessions & LTC Osteoporosis toolkit; Assigned to Arm(s): Educ sessions & LTC Osteoporosis toolkit
B: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Teaching material, Behavioral: Pre-visit reflection tool, Behavioral: Dialogue tool, Behavioral: Educational session for GPs, Behavioral: Symptom assessment scale | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational session for GPs, Behavioral: Symptom assessment scale | Intervention Type: BEHAVIORAL; Name: Teaching material; Assigned to Arm(s): Intervention Group | Intervention Type: BEHAVIORAL; Name: Pre-visit reflection tool; Assigned to Arm(s): Intervention Group | Intervention Type: BEHAVIORAL; Name: Dialogue tool; Assigned to Arm(s): Intervention Group | Intervention Type: BEHAVIORAL; Name: Educational session for GPs; Assigned to Arm(s): Control Group, Intervention Group | Intervention Type: BEHAVIORAL; Name: Symptom assessment scale; Assigned to Arm(s): Control Group, Intervention Group
C: Arm Label: INH (Intervention Nursing Homes); Type: EXPERIMENTAL; Interventions: Other: TIME | Arm Label: CNH (Control Nursing Homes); Type: ACTIVE_COMPARATOR; Interventions: Other: Education-only intervention | Intervention Type: OTHER; Name: TIME; Assigned to Arm(s): INH (Intervention Nursing Homes) | Intervention Type: OTHER; Name: Education-only intervention; Assigned to Arm(s): CNH (Control Nursing Homes)
D: Arm Label: Self management; Type: EXPERIMENTAL; Interventions: Behavioral: Self management program | Intervention Type: BEHAVIORAL; Name: Self management program; Assigned to Arm(s): Self management | Intervention Type: BEHAVIORAL; Name: self management program; Assigned to Arm(s): Self management

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Interdisciplinary Knowledge Translation Intervention in Long-term Care: The Vitamin D and Osteoporosis Study (ViDOS) Pilot Cluster Randomized Controlled Trial
Brief Summary: The research question is, does a multifaceted, multidisciplinary intervention including small groups, chart audits and point of care tools, increase the number of people receiving optimal vitamin D therapy in the long term care (LTC) setting? Secondary outcomes include the number of falls and fractures experienced by the residents in each LTC home and the number of residents receiving appropriate bisphosphonate therapy.


Options:
A: Arm Label: Training course for practice nurses in autonomy support; Type: EXPERIMENTAL; Interventions: Behavioral: Training course for practice nurses in autonomy support | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training course for practice nurses in autonomy support; Assigned to Arm(s): Training course for practice nurses in autonomy support
B: Arm Label: LTC Osteoporosis Toolkit Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Educ sessions & LTC Osteoporosis toolkit; Type: ACTIVE_COMPARATOR; Interventions: Other: Educ sessions & LTC Osteoporosis toolkit | Intervention Type: OTHER; Name: Educ sessions & LTC Osteoporosis toolkit; Assigned to Arm(s): Educ sessions & LTC Osteoporosis toolkit
C: Arm Label: Educational multifaceted intervention; Type: EXPERIMENTAL; Interventions: Other: Multidisciplinary and multifaceted educational intervention. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Multidisciplinary and multifaceted educational intervention.; Assigned to Arm(s): Educational multifaceted intervention
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Information feedback | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Information feedback | Intervention Type: BEHAVIORAL; Name: Information feedback; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Information feedback; Assigned to Arm(s): Arm 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Interdisciplinary Knowledge Translation Intervention in Long-term Care: The Vitamin D and Osteoporosis Study (ViDOS) Pilot Cluster Randomized Controlled Trial
Brief Summary: The research question is, does a multifaceted, multidisciplinary intervention including small groups, chart audits and point of care tools, increase the number of people receiving optimal vitamin D therapy in the long term care (LTC) setting? Secondary outcomes include the number of falls and fractures experienced by the residents in each LTC home and the number of residents receiving appropriate bisphosphonate therapy.


Options:
A: Arm Label: 1; Type: N/A; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): 1
B: Intervention Type: BEHAVIORAL; Name: Opinion Leaders, Academic Detailing, Reminders, and Feedback; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Lifestyle Counselling; Opinion Leader Influence Statements; Assigned to Arm(s): N/A
D: Arm Label: LTC Osteoporosis Toolkit Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Educ sessions & LTC Osteoporosis toolkit; Type: ACTIVE_COMPARATOR; Interventions: Other: Educ sessions & LTC Osteoporosis toolkit | Intervention Type: OTHER; Name: Educ sessions & LTC Osteoporosis toolkit; Assigned to Arm(s): Educ sessions & LTC Osteoporosis toolkit

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Interdisciplinary Knowledge Translation Intervention in Long-term Care: The Vitamin D and Osteoporosis Study (ViDOS) Pilot Cluster Randomized Controlled Trial
Brief Summary: The research question is, does a multifaceted, multidisciplinary intervention including small groups, chart audits and point of care tools, increase the number of people receiving optimal vitamin D therapy in the long term care (LTC) setting? Secondary outcomes include the number of falls and fractures experienced by the residents in each LTC home and the number of residents receiving appropriate bisphosphonate therapy.


Options:
A: Intervention Type: BEHAVIORAL; Name: Opinion leader generated and endorsed evidence summaries; Assigned to Arm(s): N/A
B: Arm Label: LTC Osteoporosis Toolkit Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Educ sessions & LTC Osteoporosis toolkit; Type: ACTIVE_COMPARATOR; Interventions: Other: Educ sessions & LTC Osteoporosis toolkit | Intervention Type: OTHER; Name: Educ sessions & LTC Osteoporosis toolkit; Assigned to Arm(s): Educ sessions & LTC Osteoporosis toolkit
C: Arm Label: Educational intervention; Type: EXPERIMENTAL; Interventions: Other: Educational intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Educational intervention; Assigned to Arm(s): Educational intervention
D: Arm Label: Provider Alert; Type: EXPERIMENTAL; Interventions: Other: Provider Alert | Arm Label: No Alert; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Provider Alert; Assigned to Arm(s): Provider Alert

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomized Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT (Fecal Microbiota Transplantation) for Recurrent Clostridium Difficile Infection
Brief Summary: The goal of this study is to determine the outcome of patients with recurrent CDI treated with fresh FMT versus frozen-and-thawed FMT in a randomized controlled trial. The specific objectives are to evaluate the safety of both types of FMT and to compare the clinical response, treatment failure and relapse rate in patients treated with fresh FMT compared to those treated with frozen-and-thawed FMT; also to assess the functional health and well-being of patients in each arm using a validated tool. The metagenomics will also be conducted from the stool samples collected from select patients from each arm: pre and post treatment and the matching donors. The metagenomics data will be used to determine the bacteria which may have contributed to the cure of CDI.


Options:
A: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Biological: RBX2660 (microbiota suspension) | Arm Label: Group B; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Group C; Type: ACTIVE_COMPARATOR; Interventions: Biological: RBX2660 (microbiota suspension), Other: Placebo | Intervention Type: BIOLOGICAL; Name: RBX2660 (microbiota suspension); Assigned to Arm(s): Group A, Group C | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Group B, Group C
B: Arm Label: Fresh FMT; Type: EXPERIMENTAL; Interventions: Biological: Fresh FMT | Arm Label: Frozen-and-Thawed FMT; Type: EXPERIMENTAL; Interventions: Biological: Frozen-and-Thawed FMT | Intervention Type: BIOLOGICAL; Name: Fresh FMT; Assigned to Arm(s): Fresh FMT | Intervention Type: BIOLOGICAL; Name: Frozen-and-Thawed FMT; Assigned to Arm(s): Frozen-and-Thawed FMT
C: Arm Label: Fecal transplantation; Type: EXPERIMENTAL; Interventions: Biological: Fecal transplantation | Arm Label: Placebo fecal transplantation; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo fecal transplant | Intervention Type: BIOLOGICAL; Name: Fecal transplantation; Assigned to Arm(s): Fecal transplantation | Intervention Type: OTHER; Name: Placebo fecal transplant; Assigned to Arm(s): Placebo fecal transplantation
D: Arm Label: Multiple-infusion FMT; Type: EXPERIMENTAL; Interventions: Drug: Vancomycin (before randomization), Biological: multiple-infusion FMT | Arm Label: Single-infusion FMT; Type: ACTIVE_COMPARATOR; Interventions: Biological: Single-infusion FMT, Drug: Vancomycin (before randomization) | Intervention Type: BIOLOGICAL; Name: Single-infusion FMT; Assigned to Arm(s): Single-infusion FMT | Intervention Type: DRUG; Name: Vancomycin (before randomization); Assigned to Arm(s): Multiple-infusion FMT, Single-infusion FMT | Intervention Type: BIOLOGICAL; Name: multiple-infusion FMT; Assigned to Arm(s): Multiple-infusion FMT

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomized Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT (Fecal Microbiota Transplantation) for Recurrent Clostridium Difficile Infection
Brief Summary: The goal of this study is to determine the outcome of patients with recurrent CDI treated with fresh FMT versus frozen-and-thawed FMT in a randomized controlled trial. The specific objectives are to evaluate the safety of both types of FMT and to compare the clinical response, treatment failure and relapse rate in patients treated with fresh FMT compared to those treated with frozen-and-thawed FMT; also to assess the functional health and well-being of patients in each arm using a validated tool. The metagenomics will also be conducted from the stool samples collected from select patients from each arm: pre and post treatment and the matching donors. The metagenomics data will be used to determine the bacteria which may have contributed to the cure of CDI.


Options:
A: Arm Label: CB-183,315, 125 mg; Type: EXPERIMENTAL; Interventions: Drug: CB-183,315, Drug: Placebo | Arm Label: CB-183,315, 250 mg; Type: EXPERIMENTAL; Interventions: Drug: CB-183,315, Drug: Placebo | Arm Label: Vancomycin, 125 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin | Intervention Type: DRUG; Name: CB-183,315; Assigned to Arm(s): CB-183,315, 125 mg, CB-183,315, 250 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): CB-183,315, 125 mg, CB-183,315, 250 mg | Intervention Type: DRUG; Name: Vancomycin; Assigned to Arm(s): Vancomycin, 125 mg
B: Intervention Type: DRUG; Name: tolevamer potassium-sodium (GT267-004); Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Nitazoxanide | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin | Intervention Type: DRUG; Name: Nitazoxanide; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vancomycin; Assigned to Arm(s): 2
D: Arm Label: Fresh FMT; Type: EXPERIMENTAL; Interventions: Biological: Fresh FMT | Arm Label: Frozen-and-Thawed FMT; Type: EXPERIMENTAL; Interventions: Biological: Frozen-and-Thawed FMT | Intervention Type: BIOLOGICAL; Name: Fresh FMT; Assigned to Arm(s): Fresh FMT | Intervention Type: BIOLOGICAL; Name: Frozen-and-Thawed FMT; Assigned to Arm(s): Frozen-and-Thawed FMT

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomized Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT (Fecal Microbiota Transplantation) for Recurrent Clostridium Difficile Infection
Brief Summary: The goal of this study is to determine the outcome of patients with recurrent CDI treated with fresh FMT versus frozen-and-thawed FMT in a randomized controlled trial. The specific objectives are to evaluate the safety of both types of FMT and to compare the clinical response, treatment failure and relapse rate in patients treated with fresh FMT compared to those treated with frozen-and-thawed FMT; also to assess the functional health and well-being of patients in each arm using a validated tool. The metagenomics will also be conducted from the stool samples collected from select patients from each arm: pre and post treatment and the matching donors. The metagenomics data will be used to determine the bacteria which may have contributed to the cure of CDI.


Options:
A: Arm Label: Fresh FMT; Type: EXPERIMENTAL; Interventions: Biological: Fresh FMT | Arm Label: Frozen-and-Thawed FMT; Type: EXPERIMENTAL; Interventions: Biological: Frozen-and-Thawed FMT | Intervention Type: BIOLOGICAL; Name: Fresh FMT; Assigned to Arm(s): Fresh FMT | Intervention Type: BIOLOGICAL; Name: Frozen-and-Thawed FMT; Assigned to Arm(s): Frozen-and-Thawed FMT
B: Arm Label: colonoscope via of FMT; Type: N/A; Interventions: Device: colonoscope | Arm Label: Transendoscopic enteral tubing; Type: N/A; Interventions: Device: transendoscopic enteral tubing | Intervention Type: DEVICE; Name: transendoscopic enteral tubing; Assigned to Arm(s): Transendoscopic enteral tubing | Intervention Type: DEVICE; Name: colonoscope; Assigned to Arm(s): colonoscope via of FMT
C: Arm Label: SER-109; Type: EXPERIMENTAL; Interventions: Biological: SER-109 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: SER-109; Assigned to Arm(s): SER-109 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Colonoscopy; Type: EXPERIMENTAL; Interventions: Drug: Fecal Microbiota Transplant (FMT) | Arm Label: Nasogastric Tube (NGT); Type: EXPERIMENTAL; Interventions: Drug: Fecal Microbiota Transplant (FMT) | Intervention Type: DRUG; Name: Fecal Microbiota Transplant (FMT); Assigned to Arm(s): Colonoscopy, Nasogastric Tube (NGT)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Amoxicillin Versus Benzyl Penicillin for Severe Childhood Pneumonia Amongst Inpatients: An Open Label Randomised Controlled Non-inferiority Trial
Brief Summary: This study seeks to determine whether clinical outcome following initial treatment of severe pneumonia with oral amoxicillin is as effective as the current standard benzyl penicillin. The study will also provide an estimate of the proportion of Kenyan children with severe pneumonia who fail treatment with a single antibiotic.


Options:
A: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: ceftobiprole plus placebo | Arm Label: 002; Type: ACTIVE_COMPARATOR; Interventions: Drug: linezolid plus ceftazidime | Intervention Type: DRUG; Name: ceftobiprole plus placebo; Assigned to Arm(s): 001 | Intervention Type: DRUG; Name: linezolid plus ceftazidime; Assigned to Arm(s): 002
B: Arm Label: Amoxicillin 45mg/kg 12 hourly; Type: EXPERIMENTAL; Interventions: Drug: Amoxicillin | Arm Label: Benzyl Penicillin 50,000IU/kg 6 hourly; Type: ACTIVE_COMPARATOR; Interventions: Drug: Benzyl penicillin | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): Amoxicillin 45mg/kg 12 hourly | Intervention Type: DRUG; Name: Benzyl penicillin; Assigned to Arm(s): Benzyl Penicillin 50,000IU/kg 6 hourly
C: Arm Label: Ampicillin arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin | Arm Label: Amoxicillin arm; Type: EXPERIMENTAL; Interventions: Drug: Amoxicillin | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): Amoxicillin arm, Ampicillin arm
D: Arm Label: Ceftobiprole medocaril; Type: EXPERIMENTAL; Interventions: Drug: ceftobiprole medocaril | Arm Label: IV standard-of-care cephalosporin; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV standard-of-care cephalosporin | Intervention Type: DRUG; Name: ceftobiprole medocaril; Assigned to Arm(s): Ceftobiprole medocaril | Intervention Type: DRUG; Name: IV standard-of-care cephalosporin; Assigned to Arm(s): IV standard-of-care cephalosporin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Influence of a Delivery System on the Efficacy of a Probiotic Intervention
Brief Summary: In the proposed work we will evaluate the efficacy of a probiotic bacterium (Bifidobacterium animalis subsp. lactis BB12) delivered in a yogurt smoothie (organism to be added before or after fermentation) or as a supplement (tablet) by assessing 1) bowel habits (transit time); 2) the ecology of the bacterial community in the GIT; and 3) immune status of healthy human volunteers. In addition to providing information about the relative efficacy of the delivery vehicles on probiotic function it will provide novel information about the influence of the yogurt smoothie alone (control) on all the parameters measured.


Options:
A: Arm Label: Lactobacillus; Type: EXPERIMENTAL; Interventions: Biological: Lactobacillus reuteri | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Lactobacillus reuteri; Assigned to Arm(s): Lactobacillus | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Bifidobacterium animalis subsp. lactis; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Bifidobacterium animalis subsp. lactis | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Bifidobacterium animalis subsp. lactis; Assigned to Arm(s): Bifidobacterium animalis subsp. lactis
C: Intervention Type: DRUG; Name: Mixture of probiotic bacteria and prebiotic oligosaccharide; Assigned to Arm(s): N/A
D: Arm Label: Yogurt smoothie without probiotic.; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Yogurt smoothie without probiotic | Arm Label: Probiotic added post fermentation.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Yogurt smoothie with probiotic added post fermentation | Arm Label: Probiotic added pre-fermentation.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Yogurt smoothie with probiotic added pre-fermentation | Arm Label: A capsule containing the probiotic.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: A capsule containing the probiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Yogurt smoothie without probiotic; Assigned to Arm(s): Yogurt smoothie without probiotic. | Intervention Type: DIETARY_SUPPLEMENT; Name: Yogurt smoothie with probiotic added post fermentation; Assigned to Arm(s): Probiotic added post fermentation. | Intervention Type: DIETARY_SUPPLEMENT; Name: Yogurt smoothie with probiotic added pre-fermentation; Assigned to Arm(s): Probiotic added pre-fermentation. | Intervention Type: DIETARY_SUPPLEMENT; Name: A capsule containing the probiotic; Assigned to Arm(s): A capsule containing the probiotic.

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treating Acutely Agitated Patients With Asenapine Sublingual Tablets: A Single-Dose, Randomized, Double-Blind Placebo Controlled Trial
Brief Summary: Our proposal is to administer asenapine to patients who are clinically agitated and in need of immediate intervention. At present there are no controlled studies that we know of that explores the use of asenapine for this purpose. Establishing the utility of asenapine for this common clinical problem will support its use as an additional treatment option in acutely agitated patients.


Options:
A: Arm Label: Placebo for AChEI and Choline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Indistinguishable placebo tablets, matching both donepezil and choline | Arm Label: AChEI and Choline; Type: EXPERIMENTAL; Interventions: Drug: Acetyl-Choline Esterase Inhibitors and Choline supplements | Intervention Type: DRUG; Name: Acetyl-Choline Esterase Inhibitors and Choline supplements; Assigned to Arm(s): AChEI and Choline | Intervention Type: DRUG; Name: Indistinguishable placebo tablets, matching both donepezil and choline; Assigned to Arm(s): Placebo for AChEI and Choline
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: atomoxetine, Behavioral: Parent Management Training | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: atomoxetine | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Parent Management Training | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: atomoxetine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3, 4 | Intervention Type: BEHAVIORAL; Name: Parent Management Training; Assigned to Arm(s): 1, 3
C: Arm Label: Arbaclofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Arbaclofen | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Arbaclofen; Assigned to Arm(s): Arbaclofen | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Asenapine; Type: EXPERIMENTAL; Interventions: Drug: Asenapine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Asenapine; Assigned to Arm(s): Asenapine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D